NCT02744599

Brief Summary

This is a small trial to test feasibility of an idea for a potential device. The investigators tested the feasibility of prompting a volunteer to breathe when their breathing had slowed down during administration of anesthetic drugs.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable healthy

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 20, 2016

Completed
Last Updated

March 15, 2019

Status Verified

March 1, 2019

Enrollment Period

1.4 years

First QC Date

April 7, 2016

Last Update Submit

March 13, 2019

Conditions

Keywords

Feasibility trial

Outcome Measures

Primary Outcomes (1)

  • Breath prompting successful rate

    Change in respiratory rate from baseline to the period 10 seconds after the breath prompt

Study Arms (2)

Device prompting

EXPERIMENTAL
Device: Prompting breaths via recorded voice, vibrating massager, and/or muscle tetany

Control

NO INTERVENTION

Patients receive standard of care

Interventions

Prompt volunteer to breathe using device to play recorded voice, massage the body, and/or apply muscle tetany

Device prompting

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesia (ASA) Class I and Class II male and female (non-pregnant/non-lactating) volunteers.
  • Normal healthy individual as indicated by medical history and a physical examination.
  • At least 18 years of age and less than 55 years of age.
  • Negative drug screen.
  • Uncomplicated airway anatomy.
  • A Body Mass Index between 18 and 32.
  • Are fully informed of the risks of entering the study and willingly provide written consent to enter the trial.
  • Female subjects of child bearing potential will have a negative urine pregnancy test on the day the study is conducted.

You may not qualify if:

  • Known or suspected neurological pathologies.
  • A history of significant alcohol or drug abuse, a history of allergy to opioids or propofol, or a history of chronic drug requirement or medical illness that is known to alter the pharmacokinetics or pharmacodynamics of remifentanil and propofol.
  • Known obstructive sleep apnea.
  • Known or suspected hypersensitivity to any compound present in the study.
  • Any potential subject suffering from medical problems that, in the judgment of the investigator, presents unacceptable risk to the volunteer are not eligible for enrollment.
  • Vulnerable subject groups such as prisoners and the mentally disabled that are traditionally excluded from medical research are also excluded.
  • The potential subject has taken any medication within 2 days prior to chosen drug administration, with the exception of oral contraceptives.
  • The potential subject is wearing artificial nails.
  • A positive urine pregnancy test (females only)
  • Female subjects who are currently lactating \& breast-feeding.
  • A positive drug-screening test.
  • The subject consumed food or fluids within 8 hours prior to start of each chosen drug administration.
  • Any medications or alcohol within 2 days prior to start of the chosen drug administration, with the exception of oral contraceptives.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Farney RJ, Johnson KB, Ermer SC, Orr JA, Egan TD, Morris AH, Brewer LM. Quantified Ataxic Breathing Can Detect Opioid-Induced Respiratory Depression Earlier in Normal Volunteers Infused with Remifentanil. Anesth Analg. 2025 Sep 1;141(3):507-515. doi: 10.1213/ANE.0000000000007124. Epub 2024 Aug 23.

  • Ermer SC, Farney RJ, Johnson KB, Orr JA, Egan TD, Brewer LM. An Automated Algorithm Incorporating Poincare Analysis Can Quantify the Severity of Opioid-Induced Ataxic Breathing. Anesth Analg. 2020 May;130(5):1147-1156. doi: 10.1213/ANE.0000000000004498.

  • Ermer S, Brewer L, Orr J, Egan TD, Johnson K. Comparison of 7 Different Sensors for Detecting Low Respiratory Rates Using a Single Breath Detection Algorithm in Nonintubated, Sedated Volunteers. Anesth Analg. 2019 Aug;129(2):399-408. doi: 10.1213/ANE.0000000000003793.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

April 7, 2016

First Posted

April 20, 2016

Study Start

October 1, 2013

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

March 15, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share